Shaoxing Xingxin New Material Co., Ltd. Class A

Shaoxing Xingxin New Material Co., Ltd. Class A

SSZSE:001358
22.76
CNY
+0.11
(+0.49%)
0.43EPS
54.86P/E
3.18BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.31
2.63
3.29
3.38
4.06
5.5
8.39
6.81
3.81
3.83
3.81
Basic EPS, GAAP
0.35
0.42
0.67
0.65
0.56
1.25
2.26
1.53
0.66
0.39
0.47
Free Cash Flow per Basic Share
0.62
0.08
0.69
0.24
0.23
0.51
1.05
0.92
0.34
-0.73
- -
Dividend per Share
0.3
0.36
0.27
0.3
0.3
0.38
0.02
0.02
0.86
0.49
0.75
Book Value per Share
1.1
1.62
2.29
2.66
2.95
3.85
6.12
12.3
11.81
11.63
11.72
Tangible Book Value per Share
0.94
1.46
2.03
2.4
2.7
3.6
5.87
12.12
11.64
10.85
10.95
Basic Weighted Avg Shares
92
92
92
92
92
92
92
93
123
124
122
Sales/Revenue/Turnover
214
243
302
311
374
508
774
630
468
475
466
Operating Margin (%)
13.14
19.19
22.36
25.01
17.74
26.94
31.15
24.16
15.79
10.22
13.93
Depreciation Expense
10
12
12
14
20
23
24
25
31
51
- -
Net Income, GAAP
32
39
62
60
51
116
209
142
81
48
58
Effective Tax Rate (%)
17.69
16.68
14.98
16.94
15.2
13
13.29
8.87
15.43
14.79
15.13
Profit Margin (%)
15.2
15.89
20.43
19.23
13.72
22.74
26.97
22.46
17.33
10.18
12.37
Working Capital
-5
39
82
71
104
187
310
1,144
1,033
802
827
LT Debt
- -
- -
- -
- -
28
48
20
- -
- -
2
1
Total Equity
101
150
211
246
272
356
565
1,515
1,457
1,431
1,444
Return on Invested Capital (%)
- -
16.34
22.35
21.79
16.76
29.96
40.63
13.14
5.23
2.98
3.7
Return on Capital (%)
- -
21.4
26.44
24.89
19.08
32.32
41.85
13.27
5.56
3.71
4.27
Return on Common Equity (%)
- -
30.75
34.19
26.14
19.77
36.77
45.35
13.61
5.46
3.35
3.97

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
26
18
18
LT Borrowings
- -
- -
- -
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
123
123
123
Market Capitalization
3,180
3,113
3,183

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
967
983
943
Cash, Cash Equivalents & STI
750
764
723
Accounts Receivable, Net
56
63
60
Inventories
108
95
112
Total Current Liabilities
165
133
117
Payables & Accruals
- -
- -
- -
ST Debt
26
18
18
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
50.39%
-1.79%
Free Cash Flow
- -
-30.48%
-313.74%
Net Income, GAAP
- -
18.15%
-40.46%
Sales/Revenue/Turnover
- -
9.09%
1.37%
Total Cash Common Dividend
- -
1,448.82%
-42.62%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
107
111
113
136
468
2025
105
113
- -
119
475
2026
117
117
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.18
0.17
0.16
0.16
0.66
2025
0.14
0.13
- -
0.03
0.39
2026
0.17
0.13
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.86
- -
- -
0.86
2025
- -
0.5
- -
- -
0.49
2026
- -
0.26
- -
- -
- -

Company Description

CEO
Hua Wei Shen
Full Time Employees
417
Sector
Process industries
Industry
Chemicals: specialty
Address
No. 2 Tuozhan Road Shaoxing ZH China 312369
IPO Date
Dec 21, 2023
Business
Shaoxing Xingxin New Materials Co Ltd (001358.SZ) engages in the research, development, production and sales of organic amine fine chemicals, including piperazine derivatives, amide series products, polyurethane catalysts and related intermediates for pharmaceutical, electronic, environmental and industrial applications. The company offers a comprehensive portfolio of piperazine series products such as piperazine anhydrous (CAS 110-85-0), 2-methylpiperazine (CAS 109-07-9), N-methylpiperazine (CAS 109-01-3), N-ethylpiperazine (CAS 5308-25-8), N-(2-hydroxyethyl)piperazine (CAS 103-76-4) and N,N'-di(2-hydroxyethyl)piperazine (CAS 122-96-3); amide and ethylenediamine derivatives including N-(2-hydroxypropyl)-1,2-ethylenediamine (CAS 123-84-2), N-(2-hydroxyethyl)ethylenediamine (CAS 111-41-1) and N,N-dimethylpropionamide (CAS 758-96-3); and polyurethane catalysts such as triethylene diamine (CAS 280-57-9), triethylene diamine 33% solution, N,N,N',N''N''-pentamethyldiethylene triamine (CAS 3030-47-5) and 2,2'-dimorpholinodiethyl ether (DMDEE, CAS 6425-39-4). These products serve pharmaceutical intermediates for drugs like rifampicin, ofloxacin and fluphenazine; electronic chemicals and solvents; environment-friendly agents for desulfurization, decarbonization and carbon capture; polyurethane foam catalysts; surfactants; dyes; pesticides; and epoxy resin curing agents. Founded in 2002 and headquartered at No. 2 Tuozhan Road, Hangzhou Bay Shangyu Economic and Technological Development Zone, Shaoxing, Zhejiang Province, China, the company operates two production bases in Zhejiang Shangyu and Anhui Dongzhi, covering over 200,000 square meters with more than 200 employees, including over 50 technicians and a research team of doctoral and master's degree holders. It targets global markets as a national high-tech enterprise, provincial "hidden champion" and "specialized-precise-special-new" SME in Zhejiang, holding leading positions with over 20% global and 70% Chinese market share in piperazine series products; certifications include ISO9001, ISO14001 and ISO45001. The firm maintains a wholly-owned subsidiary, Anhui Xingxin Company established in 2008, and collaborates with Tianjin University on an electronic chemicals R&D center. In July 2025, Shaoxing Xingxin New Materials announces plans to invest in a polyene polyamine production project, representing a strategic expansion into advanced polymer materials. The company continues to innovate in wet electronic chemicals for photoresist stripping in LCD panel processes and environment-friendly desulfurization/decarbonization agents supporting China's carbon peak and neutrality goals, building on its established R&D centers and technological partnerships. No major acquisitions, funding rounds or reorganizations are reported in the last two years.